Literature DB >> 4029031

In vitro combination-effect of temocillin with ticarcillin and aminoglycosides on gram-negative and gram-positive bacteria.

H M Just, C Becker, J Gieringer, A Wenz, M Bassler, F Daschner.   

Abstract

The in vitro efficacy of temocillin in combination with ticarcillin and with gentamicin, tobramycin, amikacin and netilmicin against 80 Gram-negative and 20 Gram-positive bacterial strains was compared by use of the checkerboard agar dilution technique. No synergistic or additive effect was seen on the Gram-positive strains. Great variations occurred between the different bacterial species, and the temocillin-ticarcillin combination had only little effect against the Pseudomonas strains tested. On average, only 12% of all strains tested were inhibited synergistically by temocillin-gentamicin combinations, and only 7 to 10% by combinations of temocillin with the other aminoglycosides. However, 25% of Gram-negative strains were inhibited synergistically and 40% of Gram-negative strains were inhibited additively by the combination of temocillin-gentamicin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029031     DOI: 10.2165/00003495-198500295-00015

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  10 in total

1.  Antibacterial activity of temocillin (BRL 17421), a new semisynthetic penicillin.

Authors:  G Pulverer; G Peters
Journal:  J Antimicrob Chemother       Date:  1982-05       Impact factor: 5.790

2.  Temocillin, in-vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers.

Authors:  R M Brown; R Wise; J M Andrews
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

3.  BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

Authors:  B Slocombe; M J Basker; P H Bentley; J P Clayton; M Cole; K R Comber; R A Dixon; R A Edmondson; D Jackson; D J Merrikin; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

4.  In vitro activity of temocillin, a new beta-lactamase-stable penicillin active against enterobacteria.

Authors:  D Greenwood; A Cowlishaw; A Eley
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

5.  Comparative in vitro study of temocillin (BRL 17421), a new penicillin.

Authors:  R Bolivar; S S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

6.  In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

7.  Antibacterial activity and beta-lactamase stability of temocillin.

Authors:  K Jules; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

8.  Comparative in-vitro activity of temocillin (BRL 17421), a new penicillin.

Authors:  A M Clarke; S J Zemcov
Journal:  J Antimicrob Chemother       Date:  1983-04       Impact factor: 5.790

9.  In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic.

Authors:  H W Van Landuyt; M Pyckavet; A Lambert; J Boelaert
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

10.  Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria.

Authors:  F Daschner; H Langmaack; M Grehn; A Steffens; M Just
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

  10 in total
  2 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Temocillin.

Authors:  Kevin Alexandre; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

Review 2.  Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic.

Authors:  Tommaso Lupia; Ilaria De Benedetto; Giacomo Stroffolini; Stefano Di Bella; Simone Mornese Pinna; Verena Zerbato; Barbara Rizzello; Roberta Bosio; Nour Shbaklo; Silvia Corcione; Francesco Giuseppe De Rosa
Journal:  Antibiotics (Basel)       Date:  2022-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.